
Palantir Technologies Inc. (NASDAQ: PLTR) stock is finding support around its 15-day simple moving average after the company announced a partnership with R1 to launch R37, an AI-driven lab focused on improving healthcare financial operations.
[content-module:CompanyOverview|NASDAQ:PLTR]This is the latest in a series of new and renewed contracts that Palantir has announced in the last 30 days. Each of these contracts adds to the company’s top line, which is well below its lofty valuation.